Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Oramed Pharm (ORMP) just unveiled an update.
Oramed Pharmaceuticals Inc. has announced the appointment of Mr. Avraham Gabay as the new Chief Financial Officer, Treasurer, and Secretary, set to begin on June 18, 2024. Gabay brings a wealth of experience, having previously held financial leadership roles at BiomX Inc., Oravax Inc., and other notable firms. He is also a certified public accountant and a member of the Israeli Bar Association. His compensation includes a monthly salary, bonuses, equity grants, and a company car, all determined by the company’s Board of Directors and Compensation Committee.
For a thorough assessment of ORMP stock, go to TipRanks’ Stock Analysis page.
